Fulcrum Therapeutics

-$0.60 (-7.18%) Today
$0.00 (0.00%) As of 9:24 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.

About FULC

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.

CEO
Bryan E Stuart
Employees
104
Headquarters
Cambridge, Massachusetts
Founded
2015

FULC Key Statistics

Market cap
316.98M
Price-Earnings ratio
—
Dividend yield
—
Average volume
611.27K
High today
$8.39
Low today
$7.67
Open price
$8.37
Volume
446.22K
52 Week high
$33.10
52 Week low
$6.85

FULC Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure